WebMay 24, 2024 · The Chimeric Therapeutics (ASX: CHM) share price dropped 3% today coinciding with an update on its cancer therapy trials. WebThe theoretical ex-rights price of $0.197 is calculated using Chimeric’s closing price on 18 February 2024 assuming proceeds from the Entitlement Offer of $18.1 million. TERP is the theoretical price at which shares should trade immediately after the ex-date for the Entitlement Offer assuming 100% take-up of the Entitlement Offer.

Chimeric a step closer to fulfilling IPO pitch on its ... - Stockhead

WebFeb 15, 2024 · Chimeric sought – and banked – $35 million in its initial public offer, but returned the cheques to investors, who are further seeking another $60 million. Given the unrequited demand, we shouldn’t be surprised the 20 … WebJan 18, 2024 · Chimeric Therapeutics’ IPO was priced at 20 cents per share. At 11am shares opened at 36 cents – representing an 80 per cent gain. This makes Chimeric by far the ASX’s most successful IPO so far in 2024 albeit only the fourth new listing this year. Chimeric Therapeutics (ASX:CHM) share price chart how to take care of dahlias

CMRX Stock Price Chimerix Inc. Stock Quote (U.S.: …

WebFeb 21, 2024 · The theoretical ex-rights price of $0.197 is calculated using Chimeric's closing price on 18 February 2024 assuming proceeds from the Entitlement Offer of $18.1 million. TERP is the theoretical price at which shares should trade immediately after the ex-date for the Entitlement Offer assuming 100% take-up of the Entitlement Offer. WebMay 24, 2024 · At market’s close, the Chimeric share price was trading at 29 cents, down 3.33%. Established in 2024, Chimeric is developing a breakthrough cancer cell therapy … Web2,000.70 +14.50(+0.73%) Chimeric Therapeutics Limited (CHM.AX) ASX - ASX Delayed Price. Currency in AUD Follow 0.0600 +0.0010 (+1.69%) At close: 04:10PM AEST 1d 5d 1m 6m YTD 1y 5y Max Full... how to take care of dental bridge